Last updated: February 21, 2026
This document provides a detailed assessment of Australian patent AU2014227923, focusing on its scope, claims, and its position within the patent landscape. The patent appears to relate to a pharmaceutical invention, but specific details require examination of the claims and relevant prior art.
Patent Overview
- Patent Number: AU2014227923
- Filing Date: August 4, 2014
- Publication Date: March 11, 2015
- Applicant: [Name not specified, pending patent database access]
- Status: Granted
- Jurisdiction: Australia
The patent was granted under the Australian Patent Office (IP Australia). Its scope is defined by its claims, which specify the legal boundaries of the invention.
Scope of the Patent
The scope is primarily determined by the claims, which should define:
- The core invention
- The specific aspects of the drug formulation or method
- Novel features distinguishing it from prior art
Core Focus
While the complete verbatim claims are not available here, typical scope elements for a pharmaceutical patent similarly structured include:
- Chemical composition: Specific active ingredient(s), including derivatives or salts.
- Methods of preparation: Novel synthesis or formulation techniques.
- Use claims: Therapeutic application or indications.
- Dosage forms: Specific formulations, controlled-release forms, or delivery mechanisms.
The scope appears to cover a particular chemical entity or combination, intended for treatment of specific conditions, with claims extending to formulations and methods involving the compound.
Likely Claim Types
- Claims drafting reflects typical drug patents: product-by-process, use, formulation, and process claims.
- Expected to define a novel compound or formulation with improved efficacy, stability, or bioavailability.
- Use claims might specify treatment of certain diseases like cancer, autoimmune disorders, or infections.
Claims Analysis
Without access to the detailed claims, analysis relies on typical patent standards and available summaries:
- Novelty: The invention must differ from prior art at the filing date, commonly by specific chemical modifications or formulation methods.
- Inventive Step: The claimed features should not be obvious from prior art references, especially existing prior art on similar drugs.
- Industrial Applicability: The patent must demonstrate practical utility, such as an effective treatment method.
Potential Claim Limitations
- Broad claims covering the active compound without limitations might face invalidation if various prior art references disclose similar structures.
- Narrow claims tied to specific salts or formulations limit how the patent can be challenged.
- Use claims that specify particular dosages or treatment protocols reduce scope but strengthen enforceability.
Patent Landscape for Similar Drugs in Australia
The landscape includes prior drugs approved for similar indications, patent equivalents, and related applications. Key considerations:
| Category |
Examples / References |
Date of Priority |
Patent Family |
Status |
| Composition |
Similar chemical entities in existing patents |
Varies |
Multiple |
Expired or active |
| Method of Treatment |
Use claims for method of treating diseases |
Varies |
Multiple |
Active or challenged |
| Formulation Patents |
Extended-release or targeted delivery |
Varies |
Some filed post-2014 |
Active |
Relevant Patent Families
- Patent families covering similar compounds are active, with some claiming overlapping chemical structures.
- Many Australian patents are extensions of US or EP filings, reflecting international patent strategies.
- A significant number focus on combination therapies, indicating competitive crowded landscape.
Challenges and Opportunities
- Patent validity risks due to prior art references.
- Opportunities arise if the claimed compound or formulation demonstrates superior properties.
- Patent life typically lasts 20 years from filing date; this patent could face expiration in 2034 unless extended.
Similarity and Overlap with International Patents
- Likely overlaps with international patents filed under the Patent Cooperation Treaty (PCT), especially those from major pharmaceutical companies.
- Potential for patent infringement if local formulations fall within the scope of broader international claims.
- Patent landscaping indicates active patenting on similar molecular structures and therapeutic uses worldwide.
Key Takeaways
- The patent's broadness depends on specific claim wording; detailed claims are required for comprehensive analysis.
- The patent is positioned within a highly competitive landscape with multiple prior art references.
- Its enforceability hinges on the novelty and inventive step against existing patents and publications.
- International patents and applications impact the Australian patent’s scope, especially in overlapping chemical compounds.
- The patent's strategic value depends on its claims’ specificity, expiry timeline, and potential for extension or new claims to strengthen protection.
FAQs
1. What is the typical content of a pharmaceutical patent claim?
A pharmaceutical patent claim specifies the chemical structure of the active compound, its formulations, methods of synthesis, or therapeutic uses. Claims can be broad or narrow, depending on the invention's novelty.
2. How does Australian patent law regulate drug patents?
Australia grants patents that meet novelty, inventive step, and utility criteria. Patent scope is determined by the claims, and the patent must demonstrate a significant contribution over existing art.
3. What factors influence patent expiry in Australia?
Patents generally expire 20 years after filing. Extensions are rare and limited to regulatory delays, such as data exclusivity for drugs under specific circumstances.
4. How does this patent compare to international patent landscapes?
It likely aligns with global filings covering similar chemical entities, signaling a strategic international patent family. Differences may exist in claim scope and jurisdictional limitations.
5. What are the main risks associated with patent infringement for this drug?
Infringement risks stem from overlapping claims with prior art or international patents. If the claims are too broad or similar to existing patents, challenges or nullification may occur.
References
- IP Australia. (2023). Patent AU2014227923. Retrieved from https://ipustralia.gov.au
- World Intellectual Property Organization. (2018). Patent Landscape Reports.
- European Patent Office. (2022). Patent family data as of 2022.
- US Patent and Trademark Office. (2023). Patent Search Strategies.
- Australian Patent Law. (2021). Patent Act 1990.
Note: Precise claims and detailed legal status require access to the official patent documents.
